Annals of Translational Medicine · 2022 · 14 citations · 23 references
MedicinePharmacologyPharmacotherapyBiochemical PharmacologyClinical PharmacologyMolecular PharmacologyCellular Responses To HypoxiaHypoxia PhysiologyAltitude Illness ManagementCerebral Edema PreventionCerebral Edema TreatmentHigh-altitude Cerebral EdemaHigh-altitude Pulmonary EdemaHypoxia-inducible Factor RegulationHypoxia-inducible Factor SignalingHypoxia-inducible Signaling
Background: Altitude sickness (AS), which is caused by rapid exposure to low amounts of oxygen at high elevations, poses a great threat to humans working and traveling in these conditions. Acute mountain sickness includes high-altitude pulmonary edema and high-altitude cerebral edema. Acetazolamide (AZ) is often used to treat pulmonary edema caused by hypoxia. Additionally, the medicinal plant Rhodiola rosea L. (Rh) is often used to prevent AS in the Qinghai-Tibet plateau. However, the mechanisms of action of Rh and AZ in the treatment of AS remain unclear. To date, no research has been conducted to determine whether their combined use has better efficacy in the treatment and prevention of AS than their separate use.
23
Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks
Paul Shannon, Andrew Markiel, Owen Ozier et al. · Genome Research · 2003 · 54.3K citations · Full text
Damian Szklarczyk, Annika L. Gable, David Lyon et al. · Nucleic Acids Research · 2018 · 19.2K citations · Full text